Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

LifePoint, Inc. LFPI OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
21/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

LifePoint, Inc. (LFPI) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 19/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is -$18,500, -101.1%/yr average growth. Net income is $15M (loss), growing at -32.7%/yr. Net profit margin is 0% (thin). Gross margin is -2604% (-2245.7 pp trend).

Balance sheet: total debt is $446,740 against $6M equity (Debt-to-Equity (D/E) ratio 0.07, conservative). Current ratio is 2.75 (strong liquidity). Debt-to-assets is 5.1%. Total assets: $9M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

LFPI SharesGrow Score Overview

41/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — LFPI

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
LFPI: -101.1%/yr revenue is, -32.7%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet LFPI: Debt-to-Equity (D/E) ratio 0.07 (conservative), Current ratio is 2.75 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.00002
Volume80
Avg Volume (30D)673
Market Cap$2.09K
Beta (1Y)-97.70
Share Statistics
EPS (TTM)-0.36
Shares Outstanding$42.3M
IPO Date1994-11-01
Employees52
CEORichard Wadley
Financial Highlights & Ratios
Revenue (TTM)$-18.5K
Gross Profit$-71.36K
EBITDA$-14.2M
Net Income$-15.23M
Operating Income$-7.5M
Total Cash$3.71M
Total Debt$446.74K
Net Debt$-3.26M
Total Assets$8.81M
Price / Earnings (P/E)-0
Price / Sales (P/S)-0.11
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS53215R1005

Price Chart

Track all markets on TradingView
LFPI
LifePoint, Inc. ↗  ·  Other OTC
Healthcare • Medical - Instruments & Supplies
0.00 52WK RANGE 0.00

People Also View

LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
 RHHBY
RHHBY
Roche Holding AG
$50.99
-0.08%
 AZN
AZN
AstraZeneca PLC
$201.21
-1.55%
 NVS
NVS
Novartis AG
$152.08
-0.85%
 MRK
MRK
Merck & Co., Inc.
$117.90
-1.72%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message